Wells Fargo & Company »

Oruka Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $401k 21k 19.23
2025-06-30 $196k 18k 11.21

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
Viking Global Investors
Deep Track Capital
BlackRock
Rtw Investments
Vanguard Group
Commodore Capital
Braidwell
venBio Select Advisor
Perceptive Advisors
Franklin Resources
Point72 Asset Management
Polar Capital Holdings

View all funds holding Oruka Therapeutics